Corrigendum to "Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19" [J. Drug Deliv. Sci. Technol. 77 (2022) 103921]

J Drug Deliv Sci Technol. 2023 Aug:85:104576. doi: 10.1016/j.jddst.2023.104576. Epub 2023 May 22.

Authors

Sally Abou Taleb¹, Yassmin Moatasim², Mohamed GabAllah², Marwa Hasanein Asfour¹

Affiliations

¹ Pharmaceutical Technology Department, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt.
² Center of Scientific Excellence for Influenza Viruses, National Research Centre, El-Buhouth Street, Dokki, Cairo, 12622, Egypt.

Abstract

[This corrects the article DOI: 10.1016/j.jddst.2022.103921.].

© 2023 Elsevier B.V. All rights reserved.

Publication types

Published Erratum